Who owns LYRA THERAPEUTICS INC?
- Ticker: LYRA
- CUSIP Number: 55234l105
Tip: Access positions for across all investors
Analyze quarterly positions in Lyra Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lyra Therapeutics stock
Who bought or sold LYRA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 13M | $3.3M | 0% | Sep 2024 |
|
| Citadel Advisors | 4.8M | $1.2M | 0% | Sep 2024 |
|
| BlackRock | 3.0M | $769k | 100% | Sep 2024 |
|
| BlackRock | 2.8M | $783k | 1763% | Jun 2024 |
|
| Samsara BioCapital | 2.8M | $715k | 0% | Sep 2024 |
|
| Vanguard Group | 1.7M | $479k | 17% | Jun 2024 |
|
| Ikarian Capital | 1.1M | $272k | 0% | Sep 2024 |
|
| Sei Investments | 998k | $256k | 100% | Sep 2024 |
|
| Morgan Stanley | 812k | $225k | 1161% | Jun 2024 |
|
| Geode Capital Management | 768k | $198k | 2% | Sep 2024 |
|
| Two Sigma Advisers | 682k | $189k | 374% | Jun 2024 |
|
| Two Sigma Investments | 491k | $136k | 167% | Jun 2024 |
|
| State Street Corporation | 260k | $72k | 106% | Jun 2024 |
|
| Everhart Financial Group | 253k | $65k | 100% | Sep 2024 |
|
| Northern Trust | 183k | $47k | 203% | Sep 2024 |
|
| ExodusPoint Capital Management | 159k | $41k | 396% | Sep 2024 |
|
| New York State Common Retirement Fund | 155k | $40k | -60% | Sep 2024 |
|
| Charles Schwab Investment Management | 112k | $29k | 0% | Sep 2024 |
|
| Acadian Asset Management | 111k | $28k | -89% | Sep 2024 |
|
| Beacon Pointe Advisors | 77k | $20k | 100% | Sep 2024 |
|
| Bank of New York Mellon | 76k | $20k | -2% | Sep 2024 |
|
| Barclays | 63k | $16k | 281% | Sep 2024 |
|
| Jpmorgan Chase & Co | 60k | $15k | 189% | Sep 2024 |
|
| Jane Street | 55k | $14k | 28% | Sep 2024 |
|
| AQR Capital Management | 54k | $14k | 100% | Sep 2024 |
|
| Bank of America Corporation | 49k | $13k | -43% | Sep 2024 |
|
| Alpine Partners VI | 46k | $13k | 100% | Jun 2024 |
|
| Rhumbline Advisers | 41k | $11k | -5% | Sep 2024 |
|
| SG Americas Securities | 36k | $9.0k | 100% | Sep 2024 |
|
| Citigroup | 35k | $9.0k | 229% | Sep 2024 |
|
| Alliancebernstein | 33k | $9.2k | 100% | Jun 2024 |
|
| Virtu Financial | 32k | $9.0k | 166% | Jun 2024 |
|
| Mirae Asset Global Etfs Holdings | 27k | $6.8k | 100% | Sep 2024 |
|
| Goldman Sachs Group | 24k | $6.7k | -93% | Jun 2024 |
|
| Invesco | 23k | $5.8k | -1% | Sep 2024 |
|
| Wells Fargo & Company | 18k | $4.5k | 0% | Sep 2024 |
|
| T. Rowe Price Associates | 18k | $5.0k | 0% | Sep 2024 |
|
| Susquehanna International | 13k | $3.3k | -84% | Sep 2024 |
|
| DLK Investment Management | 12k | $3.1k | 0% | Sep 2024 |
|
| Tower Research Capital | 6.8k | $1.9k | -24% | Jun 2024 |
|
| Royal Bank of Canada | 6.2k | $0 | 27% | Sep 2024 |
|
| Summit Investment Advisors | 4.7k | $1.2k | 0% | Sep 2024 |
|
| Simplex Trading | 4.2k | $1.0k | -97% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 3.7k | $950.900000 | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 3.5k | $900.948300 | 0% | Sep 2024 |
|
| Amalgamated Bank | 1.7k | $0 | 0% | Sep 2024 |
|
| Advisor Group Holdings | 1.4k | $357.866600 | -31% | Sep 2024 |
|
| Brian McDonald | 1.2k | $297.978900 | 0% | Sep 2024 |
|
| CWM | 737.00 | $0 | 100% | Sep 2024 |
|
| Capital Performance Advisors | 533.00 | $136.981000 | 100% | Sep 2024 |
|
| Jones Financial Companies, L.L | 500.00 | $133.000000 | 100% | Sep 2024 |
|
| Sterling Capital Management | 88.00 | $23.003200 | 100% | Sep 2024 |
|
| Northwestern Mutual Wealth Management Company | 70.00 | $17.997000 | 100% | Sep 2024 |
|
| Farther Finance Advisors | 38.00 | $10.001600 | 0% | Sep 2024 |
|
| NISA Investment Advisors | 37.00 | $10.001100 | 100% | Sep 2024 |
|
Who sold out of Lyra Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Rosalind Advisors | Jun 2024 | 1.0M | $286k |
| Tri Locum Partners | Mar 2024 | 979k | $6.1M |
| Verition Fund Management | Mar 2024 | 768k | $4.8M |
| Parkman Healthcare Partners | Mar 2024 | 642k | $4.0M |
| Caption Management | Jun 2024 | 247k | $68k |
| Superstring Capital Management | Mar 2024 | 145k | $904k |
| Qube Research & Technologies | Mar 2024 | 132k | $820k |
| Clearline Capital | Jun 2024 | 119k | $33k |
| Bridgeway Capital Management | Mar 2024 | 87k | $540k |
| XTX Topco | Jun 2024 | 34k | $9.4k |
| Letko, Brosseau & Associates | Jun 2024 | 32k | $8.8k |
| Balyasny Asset Management | Mar 2024 | 32k | $196k |
| Y-Intercept | Jun 2024 | 28k | $7.6k |
| OMERS Administration Corporation | Mar 2024 | 22k | $138k |
| Dimensional Fund Advisors | Jun 2024 | 22k | $5.9k |
| Millennium Management | Jun 2024 | 20k | $5.6k |
| Squarepoint Ops | Mar 2024 | 12k | $73k |
| Leucadia National Corporation | Mar 2024 | 11k | $71k |
| Macquarie Group | Mar 2024 | 1.4k | $8.937500 |